Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy (Q33492374)

27 July 2017

1 reference

title

Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy (English)

1 reference

27 July 2017

Hochstetler LA

1 reference

27 July 2017

Flanigan MJ

series ordinal

1 reference

27 July 2017

Lager DJ

series ordinal

1 reference

27 July 2017

publication date

1 March 1994

1 reference

American Journal of Kidney Diseases

27 July 2017

published in

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

27 July 2017

page(s)

444-450

1 reference

HUS and TTP: variable expression of a single entity

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Rethinking the diagnostic criteria for thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation--successful treatment with plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Thrombotic thrombocytopenic purpura: treatment with plasmapheresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Should intravenous immunoglobulin G be first-line treatment for acute thrombotic thrombocytopenic purpura? Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Cyclosporine-induced renal dysfunction in experimental animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

The efficacy of OKT3 in vascular rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Safety of immunoglobulin preparations with respect to transmission of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Clinical uses of intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

Haemolytic uraemic syndrome during FK506 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981010-9

7 January 2021

10.1016/S0272-6386(12)81010-9

Identifiers

DOI

1 reference

27 July 2017

1 reference